Possibly, targeting epigenetic mechanisms and/or exogenous ST5 contribute to blocking the proliferation and the metastasis of breast cancer and may be used as a promising advanced therapeutic method for metastatic breast cancer. Here, DENND2B is linked to breast carcinoma.